Drug
HS 10506
HS 10506: highest development phase Phase 1, developed by Hansoh Pharmaceutical. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Hansoh Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| HS-10506 NCT05953506 | Phase 1 | Healthy |
| HS-10506, Itraconazole NCT07535970 | Phase 1 | Healthy Participants |
Latest
No recent events.
Follow HS 10506 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.